Clinical Trials Logo

Clinical Trial Summary

This study will prospectively assess the impact and relevance of several risk factors for children with severe acute asthma (SAA) or acute wheeze that have been identified in retrospective studies. Secondary we will assess short-term medical and psychosocial functioning in patient (and parents) admitted to a PICU for SAA/acute wheeze versus a control group admitted to a MC for SAA/acute wheeze.


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT02936778
Study type Observational
Source Erasmus Medical Center
Contact
Status Completed
Phase
Start date August 2016
Completion date April 2019

See also
  Status Clinical Trial Phase
Completed NCT03493503 - Status Asthmaticus on the PICU; Intravenous Salbutamol Phase 4